HADEEL H. SAMARKANDI
Riyadh,Saudi Arabia
Summary
Board-certified oncology pharmacy leader with over a decade of progressive leadership in oncology pharmacy. Extensive experience directing pharmacy services, building residency programs, and leading national initiatives in CAR-T and stem cell therapy. Proven record of strategic leadership, cost optimization, and multidisciplinary collaboration, with recognition as a national and international speaker and researcher. Committed to advancing institutional performance and patient outcomes at the Director/Head level.
Overview
9
9
years of professional experience
Work history
Acting Head | Oncology Pharmacy Services
KFSHRC
Riyadh
2025.01 - 2025.09
- Direct strategic and operational leadership for Oncology Pharmacy Services overseeing 99 employees
- Led implementation of institutional oncology policies, including CAR-T and SCT.
- Championed cross-institution collaborations with national oncology societies.
- Aligning resources to improve pharmacy budget utilization.
Manager | KACO&LD Pharmacy
KFSHRC
Riyadh
2020.09 - Current
- Managed KACO&LD outpatient and inpatient operations with 43 staff under direct supervision
- Implemented quality improvement program reducing cost.
- Optimized formulary management by ensuring staff compliance to dispensing restrictions
Hematology/Oncology Clinical Pharmacist & Consultant
KFSHRC
Riyadh
2018.01 - 2025.09
- Provided advanced hematology/oncology clinical consultation for high-risk patients annually
- Led development of CAR-T protocols for standardization.
- Developed chemotherapy home administration pathways improving patients satisfaction and reducing cost by reducing hospital admissions and patients visits.
Program Director | Hematology Oncology Pharmacy Residency
KFSHRC
Riyadh
2023.01 - 2025.07
- Directed postgraduate residency program, training 2-3 residents annually
- Worked on accreditation renewal and enhanced program’s national reputation.
Staff Clinical Pharmacist
KFSHRC
Riyadh
2016.10 - 2017.12
- Delivered comprehensive clinical pharmacy services in to almost 40 patients in inpatient settings.
- Collaborated with multidisciplinary teams to optimize therapeutic regimens and improve patient safety.
Education
Healthcare Leadership Program -
KFSHRC
Riyadh, Riyadh Region 2023.07 - 2023.12
PGY-2 Pharmacy Residency Program - Hematology Oncology
KFSHRC
Riyadh, Riyadh Region 2018.01 - 2018.12
PGY-1 Pharmacy Residency Program - Pharmacy Practice Residency
KFSHRC
Riyadh, Riyadh Region 2014.10 - 2016.09
Bachelor of Pharmacy - Doctor of Pharmacy (Pharm.D.)
King Saud University
2008.06 - 2014.06
Licentiate degree - Board Certified Oncology Pharmacist
American Pharmacists Association
Riyadh, Riyadh Region 2019.12 -
Skills
- Problem-solving
- Leadership
Affiliations
- - Coordinator, Plasma Derivative Pharmaceutical Committee (2024 – Present)
- - Member, Formulary & Therapeutic Subcommittee (2023 – Present)
- - Member, Antibiotic Utilization Subcommittee (2023 – Present)
- - Member, CAR-T Cell Oversight Committee (2021 – Present)
- - Member, SCT & CT Committee (2021 – Present)
- - Member, Chemotherapeutics Subcommittee (2018 – Present)
Publications
- - Samarkandi H, et al. Excellent Outcomes of HLA Matched Related Donor Transplant for Severe Sickle Cell Disease. 2023.
- - Samarkandi H, et al. Superior Outcome of Bone Marrow Transplantation in Severe Aplastic Anemia. 2023.
- - Samarkandi H, et al. Role of Anti-CD38 Monoclonal Antibodies in Adult Hematological Diseases. 2023.
- - Samarkandi H, et al. Outcome of CAR-T Therapy in Relapsed/Refractory NHL: Real World Data. 2023.
- - Samarkandi H, et al. Cancer Management in Saudi Arabia: National Recommendations. 2021. Full list available upon request.
- - Speaker, MEA COE 2024: Role of Clinical Pharmacist in Hematology Malignancies
- - Speaker, Arab International Pharmacy Congress 2024: Navigating CAR-T Therapy
- - Invited Lecturer, SFDA 2023: Practical Considerations in CAR-T Therapy
- - Speaker, SSCP International Conference 2022
- - Speaker, SOPA and SOHO Meetings (2019–2024)
Timeline
Acting Head | Oncology Pharmacy Services
KFSHRC
2025.01 - 2025.09
Healthcare Leadership Program -
KFSHRC
2023.07 - 2023.12
Program Director | Hematology Oncology Pharmacy Residency
KFSHRC
2023.01 - 2025.07
Manager | KACO&LD Pharmacy
KFSHRC
2020.09 - Current
Licentiate degree - Board Certified Oncology Pharmacist
American Pharmacists Association
2019.12 -
PGY-2 Pharmacy Residency Program - Hematology Oncology
KFSHRC
2018.01 - 2018.12
Hematology/Oncology Clinical Pharmacist & Consultant
KFSHRC
2018.01 - 2025.09
Staff Clinical Pharmacist
KFSHRC
2016.10 - 2017.12
PGY-1 Pharmacy Residency Program - Pharmacy Practice Residency
KFSHRC
2014.10 - 2016.09
Bachelor of Pharmacy - Doctor of Pharmacy (Pharm.D.)
King Saud University
2008.06 - 2014.06